Light-induced expression of gRNA allows for optogenetic gene editing of T lymphocytes in vivo
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Diego Velasquez Pulgarin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Medicine, Department of Medicine (K2), Karolinska Institutet, Karolinska University Hospital, 171 64 Stockholm, Sweden. Hauptthemen laut MEDLINE: Gene Editing, Optogenetics, RNA, Guide, CRISPR-Cas Systems, T-Lymphocytes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancerfonden, Whitaker Foundation, NIH HHS.
Abstract (Originalsprache)
There is currently a lack of tools capable of perturbing genes in both a precise and a spatiotemporal fashion. The flexibility of CRISPR (clustered regularly interspaced short palindromic repeats), coupled with light’s unparalleled spatiotemporal resolution deliverable from a controllable source, makes optogenetic CRISPR a well-suited solution for precise spatiotemporal gene perturbations. Here, we present a new optogenetic CRISPR tool (Blue Light-inducible Universal VPR-Improved Production of RGRs, BLU-VIPR) that diverges from prevailing split-Cas design strategies and instead focuses on optogenetic regulation of guide RNA (gRNA) production. We engineered BLU-VIPR around a new potent blue-light activated transcription factor (VPR-EL222) and ribozyme-flanked gRNA. The BLU-VIPR design is genetically encoded and ensures precise excision of multiple gRNAs from a single messenger RNA transcript. This simplified spatiotemporal gene perturbation and allowed for several types of optogenetic CRISPR, including indels, CRISPRa, and base editing. BLU-VIPR also worked in vivo with cells previously intractable to optogenetic gene editing, achieving optogenetic gene editing in T lymphocytes in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Molecular Medicine, Department of Medicine (K2), Karolinska Institutet, Karolinska University Hospital, 171 64 Stockholm, Sweden.
- Department of Hematology, St Jude Children's Research Hospital, Memphis, TN 38105, United States.
- Department of Medicine (H7), Karolinska Institutet, Karolinska University Hospital, 141 83 Huddinge, Sweden.
- Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, United States.
- Department of Biomedical Engineering, University of Memphis, Memphis, TN 38152, United States.
ORCID-Profile: Alexander Espinosa
Förderung
- Cancerfonden
- Whitaker Foundation
- NIH HHS
- NIAMS NIH HHS
- Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- National Institutes of Health
Zitieren
APA
Pulgarin, D. V., Pelo, N., Ferrandiz, L., Tršelič, T., Nyberg, W. A., Bowlin, G., & Espinosa, A. (2025). Light-induced expression of gRNA allows for optogenetic gene editing of T lymphocytes in vivo. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf213
Vancouver
Pulgarin DV, Pelo N, Ferrandiz L, Tršelič T, Nyberg WA, Bowlin G, et al. Light-induced expression of gRNA allows for optogenetic gene editing of T lymphocytes in vivo. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf213
BibTeX
@article{Pulgarin2025,
author = {Pulgarin, Diego Velasquez and Pelo, Nathalie and Ferrandiz, Lin and Tršelič, Tilen and Nyberg, William A and Bowlin, Gary and Espinosa, Alexander},
title = {Light-induced expression of gRNA allows for optogenetic gene editing of T lymphocytes in vivo},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf213}
}
EUVIMED